Spyre Therapeutics Overview
Spyre Therapeutics Target Price
Analysts' 12-month price predictions for SYRE.
Get informed when a big investor buys or sells
+ FollowShare Price
$73.52
Average Target Price
$88.64
20.6% upside
20.6% upside11 analysts in the last 4 months
High: $107 | Low: $49
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-12 | Deutsche Bank | $102 | 38.7% upside |  |
| 2026-05-06 | Stifel NicolausAlex Thompson | $107 | 45.5% upside | |
| 2026-04-14 | Robert W. Baird | $90 | 22.4% upside | |
| 2026-04-14 | Wells Fargo | $90 | 22.4% upside | |
| 2026-04-14 | Deutsche Bank | $88 | 19.7% upside | |
| 2026-04-13 | Raymond James | $80 | 8.8% upside | |
| 2026-04-13 | WedbushDavid Nierengarten | $80 | 8.8% upside | |
| 2026-04-13 | Leerink Partners | $106 | 44.2% upside | |
| 2026-04-13 | BTIGJulian Harrison | $98 | 33.3% upside | |
| 2026-04-13 | Jefferies | $85 | 15.6% upside | |
| 2026-03-16 | William Blair | $49 |  33.4% downside | |
| 2025-12-17 | Mizuho Securities | $53 | 27.9% downside | |
| 2025-09-26 | Deutsche Bank | $43 | 41.5% downside | |
| 2024-11-12 | Stifel NicolausAlex Thompson | $71 | 3.4% downside | |
| 2024-10-17 | Robert W. BairdColleen Kusy | $50 | 32% downside | |
| 2024-10-15 | Wells FargoYanan Zhu | $40 | 45.6% downside | |
| 2024-05-10 | BTIGJulian Harrison | $40 | 45.6% downside | |